Showing results (2141-2150 of 25,162) with videos related to

Sort By:
Pageof 2,517
Oncotarget|February 24, 2022
The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancerAlexander W Pohlman, Hita Moudgalya, Lia Jordano, et al.
Oncotarget|February 24, 2022
The long winding road to the safer glucocorticoid receptor (GR) targeting therapiesEkaterina A Lesovaya, Daria Chudakova, Gleb Baida, et al.
Oncotarget|March 7, 2022
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myelomaNancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Oncotarget|March 7, 2022
Correction: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14Weiliang Chen, Tongliang Xia, Donghai Wang, et al.
Oncotarget|August 14, 2018
High-throughput sequencing of murine immunoglobulin heavy chain repertoires using single side unique molecular identifiers on an Ion Torrent PGMJean-Philippe Bürckert, William J Faison, Danielle E Mustin, et al.
Oncotarget|August 14, 2018
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot studySvetomir N Markovic, Filippo Galli, Vera J Suman, et al.
Oncotarget|August 14, 2018
The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximabMatthias F Froelich, Sebastian Stintzing, Jörg Kumbrink, et al.
Oncotarget|August 14, 2018
Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemiaNeetu Singh, Anil Kumar Tripathi, Dinesh Kumar Sahu, et al.
Oncotarget|June 15, 2018
Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccineEita Sasaki, Haruka Momose, Yuki Hiradate, et al.
Oncotarget|June 15, 2018
Suppression of focal adhesion formation may account for the suppression of cell migration, invasion and growth of non-small cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitorsElizabeth Ntantie, Michaela J Allen, Jerrine Fletcher, et al.
Pageof 2,517